Identification of a number of proteins overexpressed in both PCOS and ovarian cancer, such as superoxide dismutase, calreticulin, vimentin, fibrinogen γ, lamin B2, and malate dehydrogenase, assured the identification of women with PCOS with an increased risk of developing this malignancy [143]. Here, LMNB2 is linked to polycystic ovary syndrome.